M1/M4 muscarinic receptor agonists (Vertex)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameM1/M4 muscarinic receptor agonists (Vertex)
Drug Alias NameVRTX-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M4 agonistsMuscarinic acetylcholine receptor M1 agonists
TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M4
Therapy Area/IndicationsSchizophreniaPainAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVertex Pharmaceuticals Gmbh
Active IndicationsN/A
Inactive IndicationsSchizophreniaPainAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A